granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change

can be summarized as follows: 1) Profit & Loss Analysis : Q4 2022 (3 Months) (Unit : Million Baht unless otherwise stated) Q4 2022 Q4 2021 Change Amount % Change Total Revenues 7,878.0 5,848.9 2,029.2

- 2019 Balance by Quarter Change Q1–19 Q4–18 Q1–18 Q1–19 VS Q4–18 Q1–19 VS Q1–18 (Million Baht: MB) (MB) % (MB) % Total Revenue 1,266.5 1,109.5 1,044.9 157.0 14.2 221.6 21.2 Total Operating Expenses

consolidated financial statements for the three-month period ended 30 June 2019 and 2020 Revenues Q2/63 % Q2/62 % Change +/(-) Revenue from hotel operations 34 6% 279 69% (88%) Revenue from property development

the successful pilot project, ABP3, completed in January which enhanced the performance of gas turbine [to lower the heat rate of the power plant, shorten the maintenance period (or add operating days

10 years and a maturity date in 2028, and bear a fixed interest rate of 4.50 percent per annum. Payment under the notes is guaranteed by the Company. The net proceeds from the issue of the new notes

PROJECTS UNDER CONSTRUCTION NON-OPERATING ITEMS 2016 2017 % change million Baht million Baht y-on-y Other revenues 172 187 8.9% Share of profit (loss) of associates 261 256 -2.0% Gain (Loss) on exchange rate

63,393,825. Significant Events Amid sluggish in property market due to the tightening mortgage policy announced by Bank of Thailand took effect on 1 May 2019, neither cancellation nor rejection rate of the

and its subsidiaries had the operation results for the year ended December 31, 2018 with the following details: unit: THB million 2018 2017 Change (THB mill.) Change (%) Revenue from Sales and Service

-1- November 29, 2018 Subject Change of payment method for investment in acquisition and sale of tap water in some areas of Phuket and some areas of Phangnga. To Director and Manager The Stock